Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins

Mostrar otras versiones (1)

The TDP-43 proteinopathies, which include amyotrophic lateral sclerosis and frontotemporal dementia, are a devastating group of neurodegenerative disorders that are characterized by the mislocalization and aggregation of TDP-43. Here we demonstrate that RNA-targeting CRISPR effector proteins, a prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeballos C, M. Alejandra, Moore, Hayden J., Smith, Tyler J., Powell, Jackson E., Ahsan, Najah S., Zhang, Sijia, Gaj, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104115/
https://www.ncbi.nlm.nih.gov/pubmed/37066174
http://dx.doi.org/10.1101/2023.04.07.536072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104115/
https://www.ncbi.nlm.nih.gov/pubmed/37066174
http://dx.doi.org/10.1101/2023.04.07.536072

Ejemplares similares